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Experts of controlled clinical trials argue that conclusions about the effects of medical interventions
should be based on clinically relevant outcomes and not on surrogates such as laboratory measurements.
There are several examples in which the effect on a clinically relevant outcome considerably diverged
from the effect on a surrogate end point (Fleming and DeMets 1996; Rothwell 2005). In this respect, the
recent paper by Davison and Gleeson (2006) is somewhat problematic.
Davison and Gleeson motivated their study by noting that heavy exertion or long-duration
exercise may increase the incidence of upper respiratory tract infection (URI) and by citing two trials in
which vitamin C reduced the risk of URI associated with marathon runs. Evidence that vitamin C
supplementation may be beneficial for people who are under heavy physical stress is, however,
substantially stronger than Davison and Gleeson present.
A recent Cochrane meta-analysis focusing on vitamin C and the common cold found six placebo-
controlled trials with participants under heavy acute physical stress (combined N = 642). In this group of
trials vitamin C reduced common cold risk by 50% (95% CI: ?34% to ?62%) (Douglas and Hemilä 2005;
Hemilä 2006). Four of the trials, including those cited by Davison and Gleeson, were carried out with
marathon runners, the fifth with Canadian soldiers in a winter exercise (Sabiston and Radomski 1974),
and the sixth with schoolchildren in a skiing camp in the Swiss Alps (Ritzel 1961). Moreover, heavy
physical stress is a prominent feature of military recruits who concomitantly have elevated risk of
pneumonia. Therefore the large (N = 674) randomized double-blind placebo-controlled trial with US
Marine recruits is particularly interesting: vitamin C reduced the incidence of pneumonia by 85% (P[2-t]
= 0.044; Pitt and Costrini 1979; Hemilä 2004, 2006).
In their trial, Davison and Gleeson compared vitamin C and control periods in the same
participants exercising with a cycle ergometer and measured changes in the immune system. Such a study
focusing on surrogates of infection susceptibility does not yield any information about whether vitamin C
supplementation actually affects the risk of URI or more severe respiratory infections – the clinically
relevant outcomes – in physically stressed people.
On the other hand, the statistically very strong effect of vitamin C on URI risk in physically
stressed people (Douglas and Hemilä 2005) calls for immunological explanations. However, if the
2purpose of a study is to provide an immunological explanation for the vitamin C effect on URI risk, the
study should concurrently validate that vitamin C indeed has effect on URI incidence at the particular
experimental conditions, because the effect has been found only in extreme physical stress. In ordinary
people vitamin C has no effect on URI risk (Douglas and Hemilä 2005). The data for URI episodes were
not collected by Davison and Gleeson and therefore we do not know whether vitamin C reduced URI
incidence in their physical stress model. If the effect of vitamin C on URI incidence is not confirmed at
the particular study conditions, we do not know whether the immunological findings have any relation to
the biological mechanisms explaining the effect of vitamin C on URI risk, the clinically relevant outcome.
A further major problem of the Davison and Gleeson trial is the very small size (N = 9).  In the
Pitt and Costrini trial, the number-needed-to-treat (NNT) to prevent one case of pneumonia with vitamin
C was 57. The NNT to prevent one case of the common cold with vitamin C was 7 in the Sabiston and
Radomski trial, and 10 in the Ritzel trial. Concluding from such NNT values, it is evident that, as a
minimum, several dozens of participants are needed at appropriate experimental conditions for a study to
analyze whether immune system changes caused by vitamin C supplementation have any correlations
with the clinical effects.
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